Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 35 - Sayı: 3

BIOCHEMICAL AND HEMATOLOGICAL PARAMETERS IN COVID-19

COVID-19’da biyokimyasal ve hematolojik parametreler

Pages
71–80
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review article, we aimed to address the parameters that are important in the diagnosis, treatment and prognosis of COVID 19, discuss their diagnostic and prognostic efficiency and their value in risk stratification.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:There is extensive research related to the changes in the hematological and biochemical tests in COVID infection.
📊
Key Findings & Data:Besides, interleukins, C reactive protein, erithrocyte sedimentation rate, procalcitonin, ferritin were used widely to assess the inflammatory process and the “cytokine storm”.
💡
Conclusion & Impact:In this review article, we aimed to address the parameters that are important in the diagnosis, treatment and prognosis of COVID 19, discuss their diagnostic and prognostic efficiency and their value in risk stratification.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

There is extensive research related to the changes in the hematological and biochemical tests in COVID infection. The complete blood count, especially leucocyte, lymphocyte and thrombocyte counts became prominent among the routine clinical chemistry tests since this is an infectious process and these tests are easy to perform. Besides, interleukins, C reactive protein, erithrocyte sedimentation rate, procalcitonin, ferritin were used widely to assess the inflammatory process and the “cytokine storm”. Some parameters are used to evaluate the complications related to the liver, kidneys and the heart. Hypercoagulopathy and thrombosis were common in this infection and the major reason for many complications seen in COVID 19. Creatine kinase, cardiac troponins, myoglobin were used to assess cardiac status; aspartat aminotransferase, albumin, lactate dehydrogenase were used broadly to assess liver function and fibrin degradation products, activated partial thromboplastin time and D dimer were used to determine the thrombotic state. In this review article, we aimed to address the parameters that are important in the diagnosis, treatment and prognosis of COVID 19, discuss their diagnostic and prognostic efficiency and their value in risk stratification.

Özet

Sistemik bir hastalık olan Koronovirüs salgınının etkilediği organ ve dokulardaki değişikliklerin, biyokimyasal parametreler üzerine etkisinin araştırıldığı birçok çalışma bulunmaktadır. Bu derlemede; hastalığın tanı, tedavi, prognozunu öngörmede katkı sağlayabilecek belli başlı parametreler ön plana çıkarılarak tanısal ve prognostik yeterliliklerinin ele alınması amaçlandı. COVID 19 hastaları için istenen rutin testler içinde asıl nedenin enfeksiyon olması ve testin kolay uygulanabilir olması nedeniyle tam kan sayımı parametreleri ve bunlardan özellikle lökosit, lenfosit ve trombosit ön plana çıkmıştır. Ayrıca inflamatuvar sürecin ve “sitokin fırtınası”nın değerlendirilmesi açısından fikir veren prokalsitonin, C Reaktif Protein, Eritrosit Sedimentasyon Hızı, interlökinler, ferritin testleri kullanılan diğer parametrelerdir. Hastalığın özellikle komplikasyonlarının değerlendirilmesinde karaciğer ve böbrek fonksiyon testleri, kardiyak belirteçlerden CK MB, kardiyak troponinler, miyoglobin, fibrin yıkım ürünü olan D dimer testi, sekonder hemostaz hakkında fikir veren protrombin ve aktive parsiyel tromboplastin zamanı testleri yaygın olarak kullanılmaktadır.

🔖

Cite This Article

DORUK, Ö. G., ÖRMEN, M., TUNCEL, P. (2022). BIOCHEMICAL AND HEMATOLOGICAL PARAMETERS IN COVID-19. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 35 - Sayı: 3, 71–80. https://ajindex.com/articles/491979

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. World Health Organization [İnternet]. [Erişim tarihi: 26 Şubat 2021]. Erişim adresi: https://www.who.int/emergencies/diseases/novelcoronavirus 2019/technical guidance/naming thecoronavirus disease (covid 2019) and the virus thatcauses it
  2. World Health Organization [İnternet]. [Erişim tarihi: 26 Şubat 2021]. Erişim adresi:
  3. TC Sağlık Bakanlığı COVID 19 Bilgilendirme Sayfası [İnternet]. [Erişim tarihi: 26 Şubat 2021]. Erişim adresi:
  4. Thompson S, Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, et al. IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID 19 Patients. Clin Chem Lab Med. 2020;58(12):2009–16
  5. Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2. Ann Intern Med. 2020;172(11):726–34
  6. Ferrari D, Motta A, Strollo M, Banfi G, Locatelli M. Routine blood tests as a potential diagnostic tool for COVID 19. Clin Chem Lab Med. 2020;58(7):1095–9. l 7. Kurstjens S, van der Horst A, Herpers R, Geerits MWL, Kluiters de Hingh YCM, Göttgens E L, et al. Rapid identification of SARS CoV 2 infected patients at the emergency department using routine testing. Clin Chem Lab Med. 2020;58(9):1587–93. l 8. O’Shea PM, Lee GR, Griffin TP, Tormey V, Hayat A, Costelloe SJ, et al. COVID 19 in adults: test menu for hospital blood science laboratories. Ir Med Sci. 2020;189(4):1147–52
  7. García de Guadiana Romualdo L, Morell García D, Morales Indiano C, Bauça JM, Alcaide Martín MJ, Esparza del Valle C, et al. Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID 19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID Spain study). Scand J Clin Lab Invest. 2021;1–7
  8. Pourbagheri Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID 19 diagnosis and prognosis. Clin Chim Acta. 2020;510:475–82
  9. Kavsak PA, de Wit K, Worster A. Emerging key laboratory tests for patients with COVID 19. Clin Biochem. 2020;81:13–4
  10. Isakov E. Calculated decisions. Cut Tool Eng. 2011;63(10):74–8
  11. Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, et al. Prediction for Progression Risk in Patients With COVID 19 Pneumonia: The CALL Score. Clin Infect Dis. 2020;71(6):1393–9
  12. Lippi G, Horvath AR, Adeli K. Editorial and Executive Summary: IFCC Interim Guidelines on Cl